Detalhe da pesquisa
1.
A real-world study of alemtuzumab in a cohort of Italian patients.
Eur J Neurol
; 29(1): 257-266, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558755
2.
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study.
Neurotherapeutics
; 18(2): 1166-1174, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844155
3.
Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients.
Sci Rep
; 10(1): 6125, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273558
4.
Effect of fingolimod action on the release of monocyte-derived microvesicles in multiple sclerosis patients.
J Neuroimmunol
; 323: 43-48, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196832
5.
Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production.
Front Neurol
; 8: 422, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878732